Birdwatch Note
2024-04-03 03:14:19 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
1)La efectividad de la vacuna ya fue establecida ensayos clinicos https://pubmed.ncbi.nlm.nih.gov/34606595/ 2)La OMS recomienda la vacuna https://www.news-medical.net/news/20231009/WHO-experts-recommend-the-use-of-Takedas-dengue-vaccine-QDENGA.aspx asi como tambien la comision nacional de inmunizaciones (CONAIN) https://www.argentina.gob.ar/sites/default/files/2024/03/conain_presentacion_07-03-2024.pdf 3) Enturbia la discusion hablando de una vacuna distinta anterior Dengvaxia que nada tiene que ver con Qdenga
Written by 119C564E48A9F5CEFF28FE35014DF24A3B612BF7EC71C67F2896C3C68ED5675A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1775199645590827112
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1775361159501062304
- noteId - 1775361159501062304
- participantId -
- noteAuthorParticipantId - 119C564E48A9F5CEFF28FE35014DF24A3B612BF7EC71C67F2896C3C68ED5675A
- createdAtMillis - 1712114059698
- tweetId - 1775199645590827112
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 1)La efectividad de la vacuna ya fue establecida ensayos clinicos https://pubmed.ncbi.nlm.nih.gov/34606595/ 2)La OMS recomienda la vacuna https://www.news-medical.net/news/20231009/WHO-experts-recommend-the-use-of-Takedas-dengue-vaccine-QDENGA.aspx asi como tambien la comision nacional de inmunizaciones (CONAIN) https://www.argentina.gob.ar/sites/default/files/2024/03/conain_presentacion_07-03-2024.pdf 3) Enturbia la discusion hablando de una vacuna distinta anterior Dengvaxia que nada tiene que ver con Qdenga
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-03 03:14:19 UTC (1712114059698) |
2024-04-03 09:33:07 UTC (1712136787526) |
CURRENTLY_RATED_HELPFUL | 2024-04-03 11:22:43 UTC (1712143363971) |
CURRENTLY_RATED_HELPFUL | 2024-04-03 09:33:07 UTC (1712136787526) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-03 05:18:48 -0500 | Rating Details | |
| 2024-04-03 04:54:09 -0500 | Rating Details | |
| 2024-04-03 04:04:15 -0500 | Rating Details | |
| 2024-04-03 03:58:04 -0500 | Rating Details | |
| 2024-04-03 03:07:33 -0500 | Rating Details | |
| 2024-04-03 02:44:57 -0500 | Rating Details | |
| 2024-04-03 01:53:25 -0500 | Rating Details | |
| 2024-04-03 01:22:13 -0500 | Rating Details | |
| 2024-04-03 01:19:08 -0500 | Rating Details | |
| 2024-04-03 01:04:54 -0500 | Rating Details | |
| 2024-04-03 00:45:29 -0500 | Rating Details | |
| 2024-04-03 00:44:16 -0500 | Rating Details | |
| 2024-04-03 00:19:06 -0500 | Rating Details | |
| 2024-04-03 00:14:05 -0500 | Rating Details | |
| 2024-04-02 23:59:13 -0500 | Rating Details | |
| 2024-04-02 23:53:10 -0500 | Rating Details | |
| 2024-04-02 23:38:32 -0500 | Rating Details | |
| 2024-04-02 23:27:59 -0500 | Rating Details | |
| 2024-04-02 23:23:35 -0500 | Rating Details | |
| 2024-04-02 23:22:36 -0500 | Rating Details | |
| 2024-04-02 23:20:15 -0500 | Rating Details | |
| 2024-04-02 23:17:55 -0500 | Rating Details | |
| 2024-04-02 23:17:37 -0500 | Rating Details | |
| 2024-04-02 23:04:51 -0500 | Rating Details | |
| 2024-04-02 22:57:23 -0500 | Rating Details | |
| 2024-04-02 22:56:28 -0500 | Rating Details | |
| 2024-04-02 22:48:00 -0500 | Rating Details | |
| 2024-04-02 22:33:53 -0500 | Rating Details | |
| 2024-04-02 22:22:36 -0500 | Rating Details | |
| 2024-04-02 22:16:25 -0500 | Rating Details | |
| 2024-04-03 19:21:51 -0500 | Rating Details | |
| 2024-04-03 18:48:30 -0500 | Rating Details | |
| 2024-04-03 15:08:16 -0500 | Rating Details | |
| 2024-04-03 13:54:28 -0500 | Rating Details | |
| 2024-04-03 13:45:16 -0500 | Rating Details | |
| 2024-04-03 11:57:42 -0500 | Rating Details | |
| 2024-04-03 10:48:36 -0500 | Rating Details | |
| 2024-04-03 10:14:59 -0500 | Rating Details | |
| 2024-04-03 10:04:16 -0500 | Rating Details | |
| 2024-04-03 09:46:38 -0500 | Rating Details | |
| 2024-04-03 09:28:04 -0500 | Rating Details | |
| 2024-04-03 09:17:28 -0500 | Rating Details | |
| 2024-04-03 08:57:55 -0500 | Rating Details | |
| 2024-04-03 08:41:54 -0500 | Rating Details | |
| 2024-04-03 08:40:39 -0500 | Rating Details | |
| 2024-04-03 08:21:26 -0500 | Rating Details | |
| 2024-04-03 08:09:57 -0500 | Rating Details | |
| 2024-04-03 07:56:00 -0500 | Rating Details | |
| 2024-04-03 07:54:18 -0500 | Rating Details | |
| 2024-04-03 07:51:45 -0500 | Rating Details | |
| 2024-04-03 07:33:20 -0500 | Rating Details | |
| 2024-04-03 07:32:00 -0500 | Rating Details | |
| 2024-04-03 07:14:48 -0500 | Rating Details | |
| 2024-04-03 07:14:43 -0500 | Rating Details | |
| 2024-04-03 06:49:22 -0500 | Rating Details | |
| 2024-04-03 06:37:40 -0500 | Rating Details | |
| 2024-04-03 06:32:05 -0500 | Rating Details | |
| 2024-04-03 06:14:35 -0500 | Rating Details | |
| 2024-04-03 06:10:01 -0500 | Rating Details | |
| 2024-04-03 06:04:46 -0500 | Rating Details | |
| 2024-04-03 05:59:48 -0500 | Rating Details | |
| 2024-04-03 05:57:45 -0500 | Rating Details | |
| 2024-04-03 05:50:23 -0500 | Rating Details | |
| 2024-04-03 05:47:41 -0500 | Rating Details | |
| 2024-04-03 05:41:59 -0500 | Rating Details | |
| 2024-04-03 05:39:15 -0500 | Rating Details | |
| 2024-04-03 05:37:45 -0500 | Rating Details | |
| 2024-04-04 19:02:49 -0500 | Rating Details | |
| 2024-04-04 12:41:05 -0500 | Rating Details | |
| 2024-04-04 11:50:47 -0500 | Rating Details | |
| 2024-04-04 11:22:47 -0500 | Rating Details | |
| 2024-04-04 09:57:29 -0500 | Rating Details | |
| 2024-04-04 08:08:15 -0500 | Rating Details | |
| 2024-04-04 05:25:23 -0500 | Rating Details | |
| 2024-04-03 21:33:04 -0500 | Rating Details | |
| 2024-04-03 20:46:58 -0500 | Rating Details | |
| 2024-04-04 21:34:02 -0500 | Rating Details | |
| 2024-04-03 09:10:02 -0500 | Rating Details | |
| 2024-04-03 09:17:32 -0500 | Rating Details | |
| 2024-04-04 18:38:02 -0500 | Rating Details | |
| 2024-04-04 14:36:02 -0500 | Rating Details | |
| 2024-04-04 14:22:12 -0500 | Rating Details | |
| 2024-04-04 11:29:42 -0500 | Rating Details | |
| 2024-04-04 11:08:45 -0500 | Rating Details | |
| 2024-04-04 09:59:00 -0500 | Rating Details | |
| 2024-04-04 08:49:53 -0500 | Rating Details | |
| 2024-04-03 21:46:37 -0500 | Rating Details | |
| 2024-04-03 21:05:44 -0500 | Rating Details | |
| 2024-04-03 17:50:29 -0500 | Rating Details | |
| 2024-04-03 16:58:39 -0500 | Rating Details | |
| 2024-04-03 15:21:31 -0500 | Rating Details | |
| 2024-04-03 13:49:47 -0500 | Rating Details | |
| 2024-04-03 12:11:54 -0500 | Rating Details | |
| 2024-04-03 11:04:35 -0500 | Rating Details | |
| 2024-04-03 11:02:34 -0500 | Rating Details | |
| 2024-04-03 10:47:25 -0500 | Rating Details | |
| 2024-04-03 10:41:46 -0500 | Rating Details | |
| 2024-04-03 10:13:17 -0500 | Rating Details | |
| 2024-04-03 09:58:50 -0500 | Rating Details | |
| 2024-04-03 09:42:34 -0500 | Rating Details | |
| 2024-04-03 09:23:55 -0500 | Rating Details | |
| 2024-04-03 09:20:53 -0500 | Rating Details | |
| 2024-04-03 09:19:04 -0500 | Rating Details | |
| 2024-04-03 08:52:19 -0500 | Rating Details | |
| 2024-04-03 08:19:06 -0500 | Rating Details | |
| 2024-04-03 08:16:22 -0500 | Rating Details | |
| 2024-04-03 08:06:41 -0500 | Rating Details | |
| 2024-04-03 08:02:04 -0500 | Rating Details | |
| 2024-04-03 07:58:39 -0500 | Rating Details | |
| 2024-04-03 07:51:26 -0500 | Rating Details | |
| 2024-04-03 07:45:37 -0500 | Rating Details | |
| 2024-04-03 07:09:04 -0500 | Rating Details | |
| 2024-04-03 07:02:41 -0500 | Rating Details | |
| 2024-04-03 07:02:21 -0500 | Rating Details | |
| 2024-04-03 06:56:31 -0500 | Rating Details | |
| 2024-04-03 06:33:09 -0500 | Rating Details | |
| 2024-04-03 06:12:41 -0500 | Rating Details | |
| 2024-04-03 06:06:31 -0500 | Rating Details | |
| 2024-04-03 05:56:15 -0500 | Rating Details | |
| 2024-04-03 05:54:45 -0500 | Rating Details | |
| 2024-04-03 05:51:58 -0500 | Rating Details | |
| 2024-04-03 05:45:36 -0500 | Rating Details | |
| 2024-04-03 05:44:42 -0500 | Rating Details | |
| 2024-04-03 05:38:34 -0500 | Rating Details | |
| 2024-04-03 04:42:17 -0500 | Rating Details | |
| 2024-04-03 04:41:31 -0500 | Rating Details | |
| 2024-04-03 04:39:38 -0500 | Rating Details | |
| 2024-04-03 04:32:18 -0500 | Rating Details | |
| 2024-04-03 04:27:19 -0500 | Rating Details | |
| 2024-04-03 04:17:18 -0500 | Rating Details | |
| 2024-04-03 04:05:24 -0500 | Rating Details | |
| 2024-04-03 04:04:21 -0500 | Rating Details | |
| 2024-04-03 03:59:43 -0500 | Rating Details | |
| 2024-04-03 03:56:05 -0500 | Rating Details | |
| 2024-04-03 02:51:34 -0500 | Rating Details | |
| 2024-04-03 02:40:50 -0500 | Rating Details | |
| 2024-04-03 02:34:05 -0500 | Rating Details | |
| 2024-04-03 01:20:57 -0500 | Rating Details | |
| 2024-04-03 00:12:10 -0500 | Rating Details | |
| 2024-04-03 00:05:35 -0500 | Rating Details | |
| 2024-04-02 23:44:19 -0500 | Rating Details | |
| 2024-04-02 23:37:50 -0500 | Rating Details | |
| 2024-04-02 23:33:11 -0500 | Rating Details | |
| 2024-04-02 23:28:43 -0500 | Rating Details | |
| 2024-04-02 23:27:07 -0500 | Rating Details | |
| 2024-04-02 23:08:03 -0500 | Rating Details | |
| 2024-04-02 22:49:51 -0500 | Rating Details | |
| 2024-04-02 22:30:27 -0500 | Rating Details | |
| 2024-04-02 22:24:11 -0500 | Rating Details |